Fibroblast growth factor-23 as a biomarker of adverse outcomes in patients with coronary artery disease: a meta-analysis

S Zheng, C Wang, H Yan, M Xu, Y Du - Biomarkers, 2022 - Taylor & Francis
Background Fibroblast growth factor-23 (FGF-23) level has been linked the adverse
outcomes in patients with coronary artery disease (CAD). The purpose of this meta-analysis …

Factors associated with 30-day major adverse cardiovascular event in acute coronary syndrome patients with non-dialysis chronic kidney disease: a retrospective …

E Ginanjar, NM Hustrini, A Mansjoer, A Hanif… - 2023 - repository.unar.ac.id
Background: Acute coronary syndrome (ACS) accounts for the majority of ischemic heart
disease-related deaths. It is known that ACS patients with chronic kidney disease (CKD) …

Rôle des toxines urémiques dans la genèse des complications de la maladie rénale chronique

S Liabeuf, TB Drueke, ZA Massy - Bulletin de l'Académie Nationale de …, 2023 - Elsevier
Résumé La maladie rénale chronique (MRC) est une affection progressive et silencieuse.
Elle s' accompagne de nombreuses complications, notamment cardiovasculaires …

The role of neutrophil lymphocyte ratio as a major adverse cardiac events predictor and its correlation with coronary severity in acute coronary syndrome patients with …

S Immanuel, E Ginanjar, FIP Nurtyas… - … Macedonian Journal of …, 2021 - oamjms.eu
BACKGROUND: Acute coronary syndrome (ACS) patients with chronic kidney disease
(CKD) are known to have a higher risk of mortality compared to ACS patients without CKD …

[PDF][PDF] Evaluation and Correlation of Urinary Micro Albumin in Early Diagnosis of Patients with Hypertension Related Chronic Kidney Disease

ZR Jabor, IS Abbass, AJ Mhaimeed - Karbala Journal of Pharmaceutical …, 2023 - iasj.net
One of the main organs targeted by hypertension, which is now understood by science to be
an inflammatory disease, is the kidney. Urinary microalbumin, serum blood urea nitrogen …